AI & Enterprise
LG CNS makes strategic investment in Cha Biotech to step up AI healthcare business
LG CNS said it will step up its digital healthcare business with Cha Bio Group by investing 10 billion won in Cha Biotech and pursuing AI-based services and platform development. The partners will launch joint AX and DX projects, starting with cloud infrastructure migration and a smart big data platform to integrate data. They also plan to develop connected healthcare services based on specialised AI models and review global expansion through Cha Bio Group’s overseas hospital network.
